Geron Corporation

NasdaqGS:GERN Voorraadrapport

Marktkapitalisatie: US$2.6b

Geron Beheer

Beheer criteriumcontroles 3/4

De CEO Geron is Chip Scarlett, benoemd in Sep2011, heeft een ambtstermijn van 13.17 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 4.92M, bestaande uit 16% salaris en 84% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.021% van de aandelen van het bedrijf, ter waarde $ 533.83K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.9 jaar en 8.9 jaar.

Belangrijke informatie

Chip Scarlett

Algemeen directeur

US$4.9m

Totale compensatie

Percentage CEO-salaris16.0%
Dienstverband CEO13.2yrs
Eigendom CEO0.02%
Management gemiddelde ambtstermijn2.9yrs
Gemiddelde ambtstermijn bestuur8.9yrs

Recente managementupdates

Why We Think Geron Corporation's (NASDAQ:GERN) CEO Compensation Is Not Excessive At All

May 03
Why We Think Geron Corporation's (NASDAQ:GERN) CEO Compensation Is Not Excessive At All

Recent updates

Geron: A Post Earnings And Funding Announcement Assessment

Nov 07

Is Geron (NASDAQ:GERN) Using Too Much Debt?

Oct 28
Is Geron (NASDAQ:GERN) Using Too Much Debt?

Geron's Rytelo Gains Traction Despite Competitive Pressures (Rating Upgrade)

Aug 12

Geron: Probabilistic And Modest Estimate Of Pricing For A Likely Acquisition

Jul 31

Does Geron (NASDAQ:GERN) Have A Healthy Balance Sheet?

Jul 12
Does Geron (NASDAQ:GERN) Have A Healthy Balance Sheet?

Geron: Innovative Rytelo Enters A Challenging MDS Market

Jun 08

Why We Think Geron Corporation's (NASDAQ:GERN) CEO Compensation Is Not Excessive At All

May 03
Why We Think Geron Corporation's (NASDAQ:GERN) CEO Compensation Is Not Excessive At All

Geron: Advisory Nod Boosts Approval Odds, But Market Position Remains Hazy

Mar 15

Geron Post 2023 Earnings - Gearing Up For Critical Imetelstat AdCom, PDUFA

Mar 05

Is Geron (NASDAQ:GERN) A Risky Investment?

Aug 25
Is Geron (NASDAQ:GERN) A Risky Investment?

Is Geron (NASDAQ:GERN) Using Debt Sensibly?

May 12
Is Geron (NASDAQ:GERN) Using Debt Sensibly?

An Intrinsic Calculation For Geron Corporation (NASDAQ:GERN) Suggests It's 46% Undervalued

Dec 20
An Intrinsic Calculation For Geron Corporation (NASDAQ:GERN) Suggests It's 46% Undervalued

Geron: A Major Catalyst For Shareholders Arrives In January - At Last

Sep 16

Is Geron Corporation (NASDAQ:GERN) Trading At A 49% Discount?

Sep 14
Is Geron Corporation (NASDAQ:GERN) Trading At A 49% Discount?

Geron rises on narrower-than-expected Q2 loss

Aug 12

Rock star Growth Puts Geron (NASDAQ:GERN) In A Position To Use Debt

Aug 05
Rock star Growth Puts Geron (NASDAQ:GERN) In A Position To Use Debt

Geron: Waiting For Godot

Jul 15

Analyse CEO-vergoeding

Hoe is Chip Scarlett's beloning veranderd ten opzichte van Geron's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$220m

Mar 31 2024n/an/a

-US$201m

Dec 31 2023US$5mUS$787k

-US$184m

Sep 30 2023n/an/a

-US$175m

Jun 30 2023n/an/a

-US$171m

Mar 31 2023n/an/a

-US$150m

Dec 31 2022US$3mUS$761k

-US$142m

Sep 30 2022n/an/a

-US$131m

Jun 30 2022n/an/a

-US$117m

Mar 31 2022n/an/a

-US$118m

Dec 31 2021US$2mUS$736k

-US$116m

Sep 30 2021n/an/a

-US$108m

Jun 30 2021n/an/a

-US$101m

Mar 31 2021n/an/a

-US$87m

Dec 31 2020US$2mUS$714k

-US$76m

Sep 30 2020n/an/a

-US$81m

Jun 30 2020n/an/a

-US$76m

Mar 31 2020n/an/a

-US$75m

Dec 31 2019US$2mUS$690k

-US$69m

Sep 30 2019n/an/a

-US$47m

Jun 30 2019n/an/a

-US$37m

Mar 31 2019n/an/a

-US$30m

Dec 31 2018US$3mUS$667k

-US$27m

Sep 30 2018n/an/a

-US$27m

Jun 30 2018n/an/a

-US$28m

Mar 31 2018n/an/a

-US$28m

Dec 31 2017US$3mUS$644k

-US$28m

Compensatie versus markt: De totale vergoeding ($USD 4.92M ) Chip } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 6.60M ).

Compensatie versus inkomsten: De vergoeding van Chip is gestegen terwijl het bedrijf verliesgevend is.

CEO

Chip Scarlett (73 yo)

13.2yrs

Tenure

US$4,924,092

Compensatie

Dr. John A. Scarlett, also known as Chip, M.D., has been the Chief Executive Officer of Geron Corporation since joining in September 2011 and has been its President since January 5, 2012. Dr. Scarlett is C...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
John Scarlett
Chairman of the Board13.2yrsUS$4.92m0.021%
$ 533.8k
Michelle Robertson
Executive VP1.2yrsUS$2.47m0%
$ 0
Andrew Grethlein
Executive VP & COO5.8yrsUS$2.42m0.00038%
$ 9.8k
Scott Samuels
Executive VP1.3yrsUS$3.61m0%
$ 0
Aron Feingold
Vice President of Investor Relations & Corporate Communicationsno datageen gegevensgeen gegevens
Shannon Odam
Senior VP & Chief People Officer5.4yrsgeen gegevensgeen gegevens
Melissa A. Behrs
Executive VP of Business Operations & Chief Alliance Officer17.8yrsUS$1.15mgeen gegevens
Edward Koval
Executive VP & Chief Business Officer2.9yrsgeen gegevensgeen gegevens
Faye Feller
Executive VP & Chief Medical Officer2.3yrsgeen gegevensgeen gegevens
James Ziegler
Executive VP & Chief Commercial Officerless than a yeargeen gegevensgeen gegevens

2.9yrs

Gemiddelde duur

60yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van GERN wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.9 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
John Scarlett
Chairman of the Board13.2yrsUS$4.92m0.021%
$ 533.8k
Gaurav Aggarwal
Independent Directorless than a yearUS$290.82k0%
$ 0
V. Lawlis
Independent Director12.7yrsUS$360.90k0%
$ 0
Elizabeth O'Farrell
Lead Independent Director5.7yrsUS$375.53k0.0056%
$ 143.6k
Robert Jay Spiegel
Independent Director14.5yrsUS$350.90k0.028%
$ 726.6k
Susan Molineaux
Independent Director12.2yrsUS$345.90k0.022%
$ 557.3k
John McDonald
Independent Director2.2yrsUS$348.40k0%
$ 0
Dawn Bir
Independent Director5.7yrsUS$343.12k0%
$ 0

8.9yrs

Gemiddelde duur

66.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van GERN wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.9 jaar).